News
This Marijuana Stock, With Its Eggs in 1 Basket, Popped 14% Last Week
When it comes to the markets' fastest growing industries, investors would have a hard time finding a group of stocks growing quicker than marijuana. According to a report from Marijuana Business....
3 Stocks to Buy for the Next Generation
Cutting-edge technology could make ABB Ltd. (NYSE: ABB), Illumina (NASDAQ: ILMN), and TransEnterix (NYSEMKT: TRXC) smart stocks for people to buy and hold for the long haul. Our Motley Fool....
BASTIDE : Avis de Réunion de l'Assemblée générale mixte du 30 novembre 2017
BASTIDE LE CONFORT MEDICAL
Société Anonyme au capital de 3.303.261 euros
Siège social : 12, avenue de la Dame, Zone euro 2000
30132 Caissargues
305 635 039 RCS NIMES
AVIS DE....
1 Small-Cap Biotech Stock to Buy Right Now
Enzymes. You may not realize it, but they're pretty important to daily life. Your high-efficiency, phosphate-free laundry detergent that removes even the most stubborn stains in cold water? That's....
Better Buy: Johnson & Johnson vs. Pfizer
They're two of the oldest, largest, and most respected healthcare companies around. But one has made investors much happier than the other in recent years. Johnson & Johnson (NYSE: JNJ) stock....
Is Pfizer Inc. a Buy?
Pfizer Inc. (NYSE: PFE) shares have risen around 12% this year, in step with the iShares US Pharmaceuticals index. With talk of another spinoff and strong sales growth, this big pharma stock looks....
MEDICREA de?voile son nouveau mode?le de de?veloppement commercial aux Etats-Unis
Medicrea dévoile son nouveau modèle de développement commercial aux Etats-Unis avec les nominations de Joseph Walland et de Richard Washburn, respectivement Directeur des ventes et Directeur....
Ionis Pharmaceuticals Tumbles on Biogen's Miss: Buy or Sell?
Ionis Pharmaceuticals (NASDAQ: IONS) lost 11% of its market value after commercialization partner Biogen (NASDAQ: BIIB) reported third-quarter sales of its drug, Spinraza, that failed to match....
NuVasive's Sluggish Sales Growth Prompts Buybacks
Modern medicine has offered some revolutionary products and techniques, and many companies are looking to help sustain the pace of medical advances. NuVasive's (NASDAQ: NUVA) specialty in spinal....
Illumina Inc. Keeps Up Its Winning Ways Thanks to NovaSeq Sales Growth
There was plenty to like when Illumina (NASDAQ: ILMN) reported its second-quarter results in August. Pretty much everything that could go right has gone right for the gene-sequencing leader.....
3 Value Stocks for Retirement
Retirement marks the crowning achievement of a lifetime of hard work and frugal saving. However, it does not mark the end of a marathon, as many believe. It merely marks the beginning of what will....
3 Healthcare Value Stocks
The words "healthcare" and "value" don't seem to go together in the stock market right now as the sector has been hot in 2017, but that's only if you look at traditional valuation metrics and not....
Visiomed Group décroche le Prix de l'Innovation du Salon des Maires et des Collectivités Locales pour VisioCheck(R), la première station de télémédecine mobile et connectée au monde de moins de 300 grammes
Paris, le 24 octobre 2017
VISIOMED GROUP (FR0011067669 – ALVMG), société spécialisée dans l'électronique médicale nouvelle génération, reçoit le Prix de l'Innovation de la catégorie Santé du....
Why Ionis Pharmaceuticals Inc. Slipped This Morning
Shares of Ionis Pharmaceuticals Inc. (NASDAQ: IONS) dipped 13% lower in early morning trading on Tuesday after its most important collaboration partner reported some disturbing third-quarter sales....
Is Regeneron Pharmaceuticals, Inc. Stock a Buy?
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stock has been a huge winner in the past. A $10,000 investment in the biotech 10 years ago would be worth more than $200,000 today. Regeneron's....
3 Top Biotech Stocks to Buy Now
You should seriously consider adding a few biotech stocks to your portfolio if you don't already own some. Why? Because they give you an opportunity to make higher returns.And the good news is....
In Case You Missed It, Johnson & Johnson Is Undergoing a Major Business Transformation
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is what you might call a staple stock. It's a common holding for growth, value, and income investors given that many of the products it....
Better Buy: Gilead Sciences, Inc. vs. Amgen
Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD) are central figures within the biotech landscape. However, these two titans of the industry are both in the process of refreshing their....
3 Small, Profitable Biotechs With Fantastic Growth
Investors could be forgiven for shying away from the stocks of small biotechs. Not only is the complex technology behind their products almost impossible for most of us to understand, the majority....
Medicrea lancera UNiD HUB, logiciel propriétaire de planification chirurgicale, lors de la NASS 2017
Medicrea lancera UNiD™ HUB, logiciel propriétaire de planification chirurgicale s'appuyant sur les technologies big data, lors de la NASS 2017
Lyon et New York, le 24 octobre 2017 – Le Groupe....
BLUELINEA : +27% de croissance du chiffre d'affaires du 3ème trimestre 2017
Bluelinea, opérateur d'objets et services connectés dédiés à l'accompagnement, au réconfort et à l'assistance des personnes âgées, handicapées ou fragiles, confirme la poursuite de sa....
Is This $13 Billion Food Security Crisis Intrexon's Next Big Opportunity?
A few years ago, engineered biology conglomerate Intrexon (NYSE: XON) acquired a pioneering company called Oxitec. While there are plenty of whacky technology platforms in next-generation biotech,....
Why Exactech Skyrocketed 31% Today
After agreeing to be taken private by global alternative asset manager TPG Capital, Exactech (NASDAQ: EXAC) jumped 31% today.Exactech makes orthopedic implant devices and related surgical....
Why MiMedx Group Inc. Is Sinking Today
Shares of MiMedx Group (NASDAQ: MDXG), a biopharmaceutical company focused on regenerative medicine, fell 10% as of 3:45 p.m. EDT on Monday. However, there doesn't appear to be any....
Fintech Joint Venture Launched: Here's Why Investors Should Take Notice
As the fintech industry matures, more and more companies in this arena are looking to either encroach on traditional banks' territory or figure out ways they can service banks to help usher them....